Cas:211311-65-8 N-[2-(4-bromophenyl)propyl]propane-2-sulfonamide manufacturer & supplier

Chemical Name:N-[2-(4-bromophenyl)propyl]propane-2-sulfonamide

CAS.NO:211311-65-8

Synonyms:propane-2-sulfonic acid (2-(4-bromo-phenyl)-propyl)-amide;QC-955;N-2-(4-bromophenyl)propyl 2-propanesulfonamide;[2-(4-bromophenyl)propyl][(methylethyl)sulfonyl]amine;N-2-(4-Bromophenyl)propyl 2-propylsulfonamide;2-Propanesulfonamide,N-[2-(4-bromophenyl)propyl];N-(2-(4-Bromophenyl)propyl)propane-2-sulfonamide

Molecular Formula:C₁₂H₁₈BrNO₂S

Molecular Weight:320.24600

HS Code:2935009090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:54.55000

Exact Mass:319.02400

LogP:4.35210

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like propane-2-sulfonic acid (2-(4-bromo-phenyl)-propyl)-amide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-(2-(4-Bromophenyl)propyl)propane-2-sulfonamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,QC-955 Use and application,[2-(4-bromophenyl)propyl][(methylethyl)sulfonyl]amine technical grade,usp/ep/jp grade.

Related News: The ban will be in place for up to 14 days, and is aimed at helping contain the spread of the Wuhan coronavirus. So far, there have been no confirmed coronavirus cases in New Zealand or any South Pacific island. N-[2-(4-bromophenyl)propyl]propane-2-sulfonamide manufacturer These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders �� in addition to Ed Damiano �� include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible. N-[2-(4-bromophenyl)propyl]propane-2-sulfonamide supplier The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term. N-[2-(4-bromophenyl)propyl]propane-2-sulfonamide vendor The ban will be in place for up to 14 days, and is aimed at helping contain the spread of the Wuhan coronavirus. So far, there have been no confirmed coronavirus cases in New Zealand or any South Pacific island. N-[2-(4-bromophenyl)propyl]propane-2-sulfonamide factory ��We believe such actions are our last resort,�� the Hospital Authority Employees Alliance, a union that formed during the city��s antigovernment protest movement, wrote in a statement.